Get the Stockscreener App
1.05
1.94%
+0.02
After Hours:
1.03
-0.02
-1.90%
China SXT Pharmaceuticals Inc stock is currently priced at $1.05, with a 24-hour trading volume of 198.58K.
It has seen a +1.94% increased in the last 24 hours and a -37.50% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $1.04 pivot point. If it approaches the $1.06 resistance level, significant changes may occur.
Previous Close:
$1.03
Open:
$1.05
24h Volume:
198.58K
Market Cap:
$593.81K
Revenue:
$1.97M
Net Income/Loss:
$-5.93M
P/E Ratio:
-0.0432
EPS:
-24.3081
Net Cash Flow:
$-151.40K
1W Performance:
+2.94%
1M Performance:
-37.50%
6M Performance:
-55.70%
1Y Performance:
-78.69%
1D Range:
$1.03
$1.10
52W Range:
$0.9401
$9.375
China SXT Pharmaceuticals Inc Stock (SXTC) Company Profile
Name
China SXT Pharmaceuticals Inc
Sector
Phone
86 523 8629 8290
Address
178 North Taidong Road, Taizhou
China SXT Pharmaceuticals Inc Stock (SXTC) Latest News
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Down 100 Points; US Manufacturing PMI Falls In December
Benzinga
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Benzinga
China SXT Pharmaceuticals Inc Stock (SXTC) Financials Data
China SXT Pharmaceuticals Inc (SXTC) Revenue 2024
SXTC reported a revenue (TTM) of $1.97 million for the quarter ending March 31, 2023, a -58.73% decline year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Net Income 2024
SXTC net income (TTM) was -$5.93 million for the quarter ending March 31, 2023, a -115.95% decrease year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Cash Flow 2024
SXTC recorded a free cash flow (TTM) of -$151.40 thousand for the quarter ending March 31, 2023, a +89.26% increase year-over-year.
China SXT Pharmaceuticals Inc (SXTC) Earnings per Share 2024
SXTC earnings per share (TTM) was -$24.31 for the quarter ending March 31, 2023, a +74.54% growth year-over-year.
About China SXT Pharmaceuticals Inc
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. The company offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of March 31, 2022, it had an end-customer base of 68 pharmaceutical companies, 14 chain pharmacies, and 20 hospitals in 10 provinces and municipalities in China. The company was founded in 2005 and is headquartered in Taizhou, China.
1.69%
1.28%
Cap:
|
Volume (24h):